Prevalence, detection, evaluation and management of chronic kidney disease

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Ackland, Penny ^a  

^a Nunhead Surgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE GLOMERULONEPHRITIS; ALPORT SYNDROME; ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; BONE DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DETERIORATION; DIABETES CONTROL; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; HEMATURIA; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERVOLEMIA; INTERSTITIAL NEPHRITIS; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALNUTRITION; MICROALBUMINURIA; MINERAL DEFICIENCY; MYELOMA; NEPHROTIC SYNDROME; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SCREENING TEST; UPPER RESPIRATORY TRACT INFECTION; VASCULITIS;

EID: 84928800726     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f7688     Document Type: Article

References (20)

1. ADVANCE Collaborative Group, Patel A, MacMahon Set al. (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572.
2. Anandarajah S, Tai T, de Lusignan S et al. (2005) The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): A manual review of 500 medical records. Nephrol Dial Transplant 20: 2089-96.
3. Baigent C, Landray MJ, Reith Cet al. (2011) SHARP Investigators: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet 377: 2181-92.
4. BAUS/RA Guidelines (2008) Joint Consensus Statement on the Initial Assessment of Haematuria http://www.renal.org/Libraries/Other-Guidlines/Haematuria-RABAUS-consensus-guideline-2008.sflb.ashx.
5. Centers for Disease Control and Prevention (2007) Prevalence of chronic kidney disease and associated risk factors: United States, 1999-2004. Morb Mortal Wkly Rep 56: 161-5.
6. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12.
7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-305.
8. Halbesma N, Jansen DF, Heymans MW et al. (2011) PREVEND Study Group: Development and validation of a general population renal risk score. Clin J Am Soc Nephrol 6: 1731-8.
9. Hallen SI, Dahl K, Oien CMet al. (2006) Follow-up of cross sectional health survey. BMJ 333: 1047.
10. HOPE Study Investigators (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Lancet 355: 253-9. See Chapter 4.
11. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensinconvertingenzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-62.
12. NICE (2006) Clinical Guideline 34: Hypertension, http://www.nice.org.uk/nicemedia/pdf/cg034quickrefguide.pdf.
13. NICE (2011) Clinical Guideline 127: Hypertension, http://www.nice.org.uk/nicemedia/live/13561/56008/56008.pdf.
14. NICE (2008) Clinical Guideline 73: Chronic kidney disease, http://www.nice.org.uk/CG073.
15. NICE (2009) Clinical Guideline 87: Type 2 diabetes, http://www.nice.org.uk/nicemedia/pdf/CG087NICEGuideline.pdf.
16. Ruggenenti P, Perna A, Gherardi Get al. (1998) Renal function and requirement for dialysis in chronic nephropathy patients on longterm ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy. Lancet 352: 1252-6.
17. Taal M (2011) Predicting renal risk in the general population: Do we have the right formula? Clin J Am Soc Nephrol 6: 1523-5.
18. UK PD Study.
19. UK Renal Registry (2009) Annual Report, http://www.renalreg.com/Reports/2009.html.
20. Vivante A, Afek A, Frenkel-Nir Y (2011) Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults at risk for endstage renal disease. JAMA 306: 729-36.